You are using an outdated browser. Please upgrade your browser to improve your experience.

pemigatinib

Pemigatinib inhibited FGFR1-3 phosphorylation and signaling and decreased cell viability in cancer cell lines with activating FGFR amplifications and fusions that resulted in constitutive activation of FGFR signaling.
Target Activities